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Abstract
Background: Prescription practices, especially in South Asian countries, have come under investigation for quality.
Although there have been no studies in Nepal that have analyzed the prescription pattern of FDCs for different
levels of health care centers, several studies from Nepal and other countries in the region have revealed poor
medicine use practices, including irrational use of fixed-dose drug combinations (FDCs). This research aimed at
assessing the utilization pattern of FDCs among primary (PHC), secondary (SHC) and tertiary health care (THC)
centers in Western region of Nepal.
Methods: A cross-sectional descriptive study was conducted at primary, secondary and tertiary health care centers
in Western Nepal. One hundred prescriptions from each health care center were chosen through systematic
random sampling. The International Network for Rational Use of Drug (INRUD) indicators were used to assess the
rationality of prescribing. Both descriptive and inferential statistics were applied. The alpha level used was 0.05.
Results: At the PHC center, 206 medicines were prescribed, of which 20.0% were FDCs. Antimicrobials were the
most prescribed FDCs (57.1%). The unit prices of all FDCs were below 100 Nepalese Price Rupees (NPRs). At the SHC
center, 309 medicines were prescribed, and 30% were FDCs. Vitamins, minerals and dietary supplements were the
most prescribed FDCs (25.8%). The costs of 63.5% of FDCs were below 100 NPRs. At the THC center, 33.5% of 270
medicines were FDCs. As at the SHC center, vitamins, minerals and dietary supplements were the most prescribed
FDCs (40.6%). The costs of 50.5% of FDCs were below 100 NPRs.
Conclusions: FDCs were used extensively at different health care centers. The number of prescription in private
centers, following established guidelines and the essential drug list (EDL), was much lower. The cost associated with
the utilization of FDCs was higher in private sectors compared to public health care centers. In certain cases, the
use of FDCs was questionable, and this study found a low use of essential medicines. Education to improve
prescription practices at different healthcare levels is recommended.
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Background
Medicine use studies are conducted to monitor, assess and
change the prescribing habits of practitioners. The main
purpose of these studies is to make health care more cost-
effective and rational [1]. Drug utilization has been de-
fined as “the marketing, distribution, prescription and use
of medicines in a society, with special emphasis on the
resulting medical, social and economic consequences” [2].
Periodic evaluations of drug utilization patterns are ne-
cessary to increase the therapeutic benefits of medicines,
decrease adverse effects and, ultimately, modify the pre-
scription of medicines as needed.
Rational prescription practices mean “making a diag-
nosis, estimating prognosis, obtaining the best possible
effect with the least number of medicines in the shortest
period and at reasonable cost and monitoring the effects
of the treatment” [3]. In both developed and developing
countries, the irrational and inappropriate use of medi-
cines is a major concern [4]. The prescribing behavior of
a practitioner depends on several factors, including com-
mercial publicity, government regulations, academic litera-
ture, patient behaviors, and influences from pharmaceutical
companies. Inappropriate responses to these factors lead to
prescription errors and irrational prescribing habits, both of
which are very common in clinical practice.
In a low-income country like Nepal, high numbers of
people lack access to medicine due to its poor availability
and restrictive cost. Though 42% of the health budget is
spent on medicines, the availability of medicines in health
posts (HPs) and clinics is inconsistent, contributing to the
higher prevalence of the inappropriate drug use [5] such as
the irrational fixed dose drug combinations (FDCs) that are
readily available in the market. In many instances, the use
of irrational FDCs is not justified. FDCs are medicines that
contain two or more active components in fixed propor-
tions in a single dosage form [6]. Rational combinations im-
proves quality of life of many people and can be of great
benefit to the healthcare system [7] such as the antitubercu-
lar medicines, antiretroviral medicines and some antihyper-
tensive medicines. Irrational combinations, on the other
hand are equally harmful such as the combination of non-
steroidal anti-inflammatory drugs (NSAIDs) with muscle
relaxants, NSAIDs with H2 blockers, cough syrups with
two or more antihistamines, steroids, antibiotics and bron-
chodilators [8]. Irrational FDCs have a combination of
medicines that may be used to treat a disorder without
achieving a correct diagnosis [4]. The FDC may not contain
the required quantity of each individual drug, and the com-
bination may not be synergistic. Health care centers in
Nepal are flooded with irrational FDCs, while the patients
are deprived of essential medicines [9].
The prevalence of irrational prescription practices, es-
pecially in South Asian countries, has led to special in-
vestigations into how and why medicines are prescribed.
Several interventions have however, been initiated
such as the banning of irrational combinations, with-
drawing them from the market and ceasing the manu-
facturing of irrational FDCs [10, 11]. Despite these
interventions, irrational FDCs are still available in the
market and are used extensively. The interventions are
not successful due to several reasons. One such reason
relates to exporting of FDCs that are banned in a par-
ticular country to the neighboring countries [12]. Such
exports hinder the interventional process of government
or individuals trying to weed out irrational combinations
from their country. Studies from Nepal and other South
Asian countries concluded that the quality of prescrip-
tion is poor, with the common overuse of antimicrobials
and the irrational use of FDCs, particularly in private
sectors [13–15]. In Nepal, the irrational and inefficient
use of medicines is prevalent at all levels of health care
[16]. Prescribing irrational FDCs is the rule rather than
the exception, with up to seven items being prescribed
for a single disease [13]. Even with the frequent use of
FDCs, finding the optimal dose and optimal combin-
ation is still a matter of trial and error. The reason many
FDCs are prescribed appears to be irrational [17],
though the practice is common at various health care
centers. A study at a tertiary care teaching hospital in
Nepal found FDCs accounted for 47% of the total medi-
cines prescribed, even though their use was inappropri-
ate in numerous cases [18]. Irrational FDCs can also
lead to adverse drug reactions (ADRs). A study involving
a community pharmacist from western Nepal reported
that the FDC of ibuprofen and paracetamol accounted
for the highest incidence of ADRs [19].
In Nepal, there have been no studies that analyzed the
prescription pattern of FDCs at different levels of health
care centers. This study was the first to analyze
utilization patterns of FDCs in private and public sec-
tors. In Nepal, primary health care (PHC) centers are
managed by the government. The secondary health care
(SHC) centers and tertiary health care (THC) centers in
our study were privately managed. Our study examined
the prevalence of FDCs and the cost associated with
their use; we can corroborate past reports of widespread
irrational FDC use in the private sector [20]. Our find-
ings may also help concerned regulatory bodies analyze
FDCs used in different health care centers to mitigate
the free flow of irrational FDCs. The study can also
create awareness among all health care professionals re-
garding the hazards associated with the irrational use of
FDCs.
Study objectives
The study was designed to accomplish the following:
1. To analyze the prescription pattern of FDCs in pri-
mary, secondary and tertiary health care centers,
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2. To categorize the FDCs prescribed from the pri-
mary, secondary and tertiary health care centers based
on their therapeutic class, and.
3. To analyze the cost associated with the FDCs pre-




A cross-sectional descriptive study was conducted from
February to May 2009, analyzing the utilization pattern
of FDCs in selected primary, secondary and tertiary
health care centers in Western Nepal.
Study site
The study was carried out in selected primary, secondary
and tertiary health care centers in Pokhara, Western re-
gional of Nepal. The details of each center are men-
tioned below.
Primary health care (PHC) center
The Nepalese PHC system operates at different levels:
PHC centers, health posts (HP) and the sub-health posts
(SHP). For the majority of the rural population, the PHC
center serves as the first level of contact with the health-
care system. In this study, the HP at the Batulechaur
Village Development Committee (VDC) of Kaski district
was selected as a PHC center. This health care center is
located approximately 10 km from Pokhara city, with an
average patient flow of 20 patients per day. This health
care center is regulated by the government, and it is the
government which caters to the primary health care needs
of Batulechaur VDC. Minor diseases like acute respiratory
infections, wounds, dental caries, skin diseases and worm
infestation are managed in these health care centers.
Secondary health care (SHC) center
Charak Hospital, a private hospital in Pokhara, was se-
lected as a SHC center. It has an average bed occupancy
of approximately 100 patients and an average outpatient
count of approximately 200 patients per day. The hos-
pital consists of various specialty departments (both
clinical and non-clinical).
Tertiary health care (THC) center
Manipal Teaching Hospital (MTH), a private institution,
was selected as a THC center for our study. MTH is a
700-bed tertiary care teaching hospital with average bed
occupancy of approximately 200 patients and an average
outpatient rate of approximately 400 per day. The hos-
pital consists of various specialty departments (both
clinical and non-clinical). The hospital caters to the
healthcare needs of patients of Western and Midwestern
region of Nepal.
Population and sampling procedure
The target population of this study is patients visiting
pharmacies of each health care setting with a prescription
from outpatient departments. Patients’ verbal informed
consent was obtained, and patients who were not willing
to participate in the study, as well as inpatients from each
health care center were excluded from the study.
Based on the time and phase of the study, sample size
was estimated for 100 patients per setting, leading to a
total of 300 patients. Systematic random sampling was
used to select patients with prescriptions from each health
care setting. Five patients were sampled every alternate
day in PHC, SHC, and THC centers for a period of three
months until 100 prescriptions were encountered.
Study tools
The International Network for Rational Use of Drug
(INRUD) encounter form was modified and used for
data collection (Additional file 1). The cost per dis-
pensed quantity was not included in the original INRUD
encounter form. Thus, the original form was modified
and divided into a prescribing indicator, a patient care
indicator and a cost indicator (USD 1 = NPR 75). In
addition, the National model list of essential medicines
for Nepal, the WHO Model List of Essential Medicines,
and the Nepalese National Formulary (NNF) were used
as standard resources to check the prescription pattern
and the medicines listed in these sources were consid-
ered rational.
Data collection procedure
Patients visiting pharmacies with a prescription from
each health care setting were enrolled in the study. The
prescriptions from the patients were used as a source of
data. The patients were interviewed after the medicines
had been dispensed to them for their knowledge regard-
ing dose, duration, and frequency of medicines. The in-
formation gathered was noted on the data collection
form (Additional file 1).
Data analysis procedure
The completed encounter forms were analyzed per the
study objectives. Parameters such as the “details of med-
icines present in different formularies and drug list,” the
“therapeutic category of medicines prescribed” and the
“cost analysis for the medicines prescribed” were ana-
lyzed. The data obtained were entered in a Microsoft
Excel spreadsheet and analyzed. Statistical Package for
the Social Sciences (SPSS) version 16.0 (SPSS Inc. Re-
leased 2007Chicago, SPSS, Inc.) was used to carry out
the descriptive and inferential statistics. A Kolmogorov-
Smirnov test was used to check the normality of the
data. A Kruskal-Wallis test was used to compare the dif-
ference between three health care centers based on cost.
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A p value of less than 0.05 was considered statistically
significant. Post-hoc analysis was carried out using
Mann-Whitney U test between two groups to determine
any differences. A Bonferroni adjustment using the for-
mula k(k-1)/2, where k is the number of groups or con-
ditions, was performed to remove the type I error. After
applying the formula, we found that any pair of data has
to achieve a significant value on a paired test smaller
than 0.05/3 = 0.017 to be significant at the 0.05 level.
Pilot study
A pilot study was carried out in selected primary, second-
ary and tertiary health care centers in Western Nepal [20].
Twenty-five, fifty and seventy-five prescriptions from each
primary, secondary and tertiary health care center, re-
spectively, were collected. The data collection form was
improved by including the parameters assessing the pa-
tients’ knowledge on medicines regarding dose, duration
and frequency. The pilot study also provided insights on
feasibility of conducting the main research.
Results
Part I: Primary health care center
Altogether, 100 prescriptions were encountered from the
PHC center. The median (IQR) age of the patients was
36 (18–60) years, and majority were female (64%). A
total of 206 medicines were prescribed, of which 20.4%
(n = 42) were FDCs. Analysis of the prescriptions was
further carried out based on the study objectives.
Details of medicines present in different formularies and
drug lists
Out of the total 42 FDCs prescribed, 90.4% (n = 38)
were from the Essential Drug List (EDL) of Nepal (3rd
Revision 2002), 95.2% (n = 40) were from the NNF, and
57.1% (n = 24) were from the World Health
Organization (WHO) Model List of Essential Medicines
(15th Edition). The details are shown in Fig. 1.
Therapeutic category of medicines prescribed
Among the 206 medicines prescribed, antimicrobials made
up to 27.1% (n = 56), and antiulcer medicines accounted
for 26.2% (n = 54). Among the 42 FDCs prescribed, 57.1%
(n = 24) were antimicrobials, and 26.1% (n = 11) were anti-
ulcer medication. The details are shown in Fig. 2.
Cost analysis for the medicines prescribed
Out of 206 medicines prescribed, 85.4% (n = 176) of
them cost less than 100 Nepalese price rupees (NPRs),
while 30 medicines were between 101 and 200 NPRs.
The cost of all the 42 FDCs prescribed was below 100
NPRs.
Part II: Secondary health care center
A total of 100 prescriptions were derived from the SHC
center. The median (IQR) age of the patients was 33
(28–45) years, and majority were female (60%). A total
of 309 medicines were prescribed, of which 30% (n = 93)
were FDCs. The prescription analysis was further carried
out based on the study objectives.
Details of medicines present in different formulations and
drug lists
Of the 93 FDCs prescribed, 6.4% (n = 6) were from the
EDL of Nepal (3rd Revision 2002), 19.3% (n = 18) were
from the NNF, and 10.7% (n = 10) were from the WHO
Model List of Essential Medicines (15th Edition). The
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Fig. 1 Number of drugs present in different formularies and drug lists in PHC center
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Therapeutic category of medicines prescribed
Among the 309 medicines prescribed, vitamins, minerals
and dietary supplements were commonly prescribed, ac-
counting for 19.7% (n = 61) of the medicines. Antimi-
crobials were even more prevalent at 22% (n = 68).
Similarly, among the 93 FDCs, the most prescribed med-
icines were vitamins, minerals and dietary supplements
at 25.8% (n = 24), followed by antimicrobials at 24.7%
(n = 23). The details are shown in Fig. 4.
Cost analysis for the medicines prescribed
Among the 309 medicines prescribed, 58.9% (n = 182)
cost less than 100 NPRs, followed by 23.6% (n = 73) with
costs in the range of 101–200 NPRs. Among the 93
FDCs, 63.4% (n = 59) were less 100 NPRs, and 22.5%
(n = 21) of the medicines were in the price range of
101–200 NPRs. The details are shown in Fig. 5.
Part III: Tertiary health care center
Altogether, 100 prescriptions were encountered from the
THC center. The median (IQR) age of the patients was
32 (19–47) years, and majority were female (66%). A
total of 270 medicines were prescribed, of which 33.5%
(n = 91) were FDCs. Further analysis was carried out
based on the study objectives.
Details of medicines present in different formularies and
drug lists
Out of the total 91 FDCs prescribed, 9.8% (n = 9) were
from the EDL of Nepal (3rd Revision 2002), 12.0%
(n = 11) were from the NNF, and 15.3% (n = 14) were
0 10 20 30 40 50 60
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Fig. 3 Number of drugs present in different formularies and drug lists in SHC center
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from the WHO Model List of Essential Medicines (15th
Edition). The details are shown in Fig. 6.
Therapeutic category of medicines prescribed
Among the 270 medicines prescribed, analgesic/antipy-
retics were the most prescribed medicines at 27%
(n = 73), followed by vitamins, minerals and dietary sup-
plements, which accounted for 25.5% (n = 69). Similarly,
among the 91 FDCs, the most prescribed medicines
were vitamins, minerals and dietary supplements with
40.6% (n = 37) as FDCs, followed by 26.3% (n = 24) that
were analgesic/ antipyretics. The details are shown in
Fig. 7.
Cost analysis for the medicines prescribed
Among the total 270 medicines prescribed, 43.7%
(n = 118) cost less than 100 NPRs, and 22.5% (n = 61)
were in the range of 101–200 NPRs. Among the 91
FDCs, 50.5% (n = 46) had prices below 100 NPRs,
followed by 29.6% (n = 27) that were in the range of
101–200 NPRs. The details are shown in Fig. 8.
Difference in the use of fixed dose drug combinations
among primary, secondary and tertiary health care centers
The difference in the use and cost of FDCs in primary,
secondary and tertiary health care centers was com-
pared. A statistically significant difference was found in
the utilization pattern of FDCs for the primary, second-
ary and tertiary health care centers (p = 0.000). The de-
tails are shown in Table 1.
A post-hoc analysis using a Mann-Whitney U test
among groups showed a statistically significant differ-
ence in primary health care centers (p = 0.000) com-
pared to the other groups. A significant difference was
observed between primary and secondary health care
centers (p = 0.000), as well as between primary and
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Fig. 5 Cost analysis for the drugs prescribed in SHC center
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tertiary health care centers (p = 0.000). There was no
significant difference between secondary and tertiary
health care centers (p = 0.998).
Discussion
This study was the first of its kind to analyze the
utilization pattern of FDCs among the three levels (pri-
mary, secondary and tertiary) of health care centers in
Nepal. The study assessed the prescribing patterns of
FDCs in these three levels of health care system based
on different formularies and drug lists. The study also
analyzed the therapeutic class of the drug prescribed and
the cost associated with it.
The PHC centers selected in this study are managed
by the government. Due to the immense human cost of
disease in Nepal, PHC centers receive the highest alloca-
tion in national health spending and about three quar-
ters of the total health budget [21]. PHC centers provide
essential health care based on a practical, socially
acceptable method made universally accessible to the in-
dividuals and community at the lowest possible cost
[22]. In our study, out of the 206 medicines prescribed,
20% were FDCs. The average number of medicines per
prescription was 2.06. Our findings are slightly lower
than studies in PHC centers in plain (also called as
Terai) districts that had 2.2 medicines per prescription
and centers in hill districts that had 2.1 medicines per
prescription [23]. In a similar study in rural districts in
Tajikistan the median number of medicines prescribed
was 3, ranging from 1 to 8 or more medicines [24].
Approximately 90% of FDCs prescribed were from the
EDL of Nepal, 95% were from the NNF, and 57% were
from the WHO Model List of Essential Medicines. In
the previous study, at the primary healthcare facilities in
the Kaski district, the percentage of medicines pre-
scribed from the EDL varied from 70.9% to 74.0% [21].
The higher rate of utilization of FDCs from EDL may be
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Fig. 6 Number of drugs present in different formularies and drug lists in THC center
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Fig. 7 Therapeutic category of drugs prescribed in THC center
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government of Nepal decided to offer essential health care
services free of charge to all citizens at all health and sub-
health posts from mid-January 2008 [26]. Antimicrobials
and antiulcer FDCs were prescribed in 57% and 26% of
the encounters, respectively. Our observations regarding
the prevalence of antimicrobials in the PHC center was
similar to that of a study in Ethiopia [27]. All the FDCs
prescribed in PHC center were below $1.25.
Secondary health care typically refers to services pro-
vided by hospitals. The SHC center selected in the study
was a private hospital. During our study period, we
found that 30% of the 309 medicines prescribed were
FDCs. The average number of medicines per prescrip-
tions was 3.09. In contrast to the finding from the PHC
center, we found that only 6.4% of FDCs encountered in
SHC center were from the EDL of Nepal, 19.3% were
from the NNF, and 10.7% were from the WHO Model
List of Essential Medicines. The most widely prescribed
FDCs were vitamins, minerals and dietary supplements,
which accounted for 24 (25.8%) of the total FDCs,
followed by 23 (24.7%) antimicrobials. The WHO has re-
moved vitamin combinations from their list with the
comment that vitamins are considered part of nutrition,
and combinations should not be used indiscriminately
[28]. Among the total FDCs encountered, 63% were less
than $1.25, and 22% were in the range of $1.2 - $2.5.
Tertiary health care refers to specialist services mostly
provided by the private medical institutions. Similar to
the SHC center, the THC center selected for our study
was a private hospital. Altogether, 270 medicines were
prescribed, out of which 33.5% were FDCs. In Nepal
health units, an average of 56% medicines were pre-
scribed by brand names, and FDC formulations contrib-
uted up to 46.6% [28]. However, a study from Western
Nepal found that FDCs accounted for only 15.8% of
medicines prescribed [4]. Similar studies in the same
hospital found that FDCs comprised 47% of all pre-
scribed medicines [18], while in Uttaranchal, India,
FDCs accounted for 59% of medicines prescribed [29].
Among the 91 FDCs encountered in the THC center,
the most prescribed medicines were vitamins, minerals
and dietary supplements, accounting for 40.6% of total
FDCs, followed by analgesic/antipyretics at 26.3%. A
study by Sarkar et al. found that the most widely pre-
scribed FDCs without a rational basis were multivitamin
combinations (31.3%) and cough and cold remedies
(17.1%) [28]. A similar study in Duwakot health care
center, Kathmandu, found that the antipyretics, antibi-
otics and NSAIDs to be the most commonly prescribed
medicines [30]. Among the 91 FDCs, 50.5% cost less
than $1.25, followed by 29.6% medicines in the range of
$1.2 - $ 2.5. The finding was similar to a study in a
teaching hospital in Pokhara, Western Nepal, where the
average cost of medicines per prescription was $2 [31].
Many medicines encountered in the study were based
on established regulatory guidelines such as the national
model list of essential medicines for Nepal, the WHO
Model List of Essential Medicines, and the NNF. In the
PHC center, however, the scenario was different than the
THC center. Out of the total 91 FDCs prescribed, only


























Fig. 8 Cost analysis of drugs prescribed in THC center
Table 1 Difference of cost (NPR) of FDCs between PHC, SHC
and THC centers (n = 226)
Health care centers Median
(IQR)
P value
Primary Health Care center (n = 42) 43 (30–54) 0.000*
Secondary Health Care center (n = 93) 84 (45–153)
Tertiary Health Care center (n = 91) 102 (55–180)
*Kruskal Wallis test at ά = 0.05
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NNF, and 15.3% were from the WHO Model List of Es-
sential Medicines. This reflects the ignorance of more
qualified physicians at secondary and tertiary levels, to-
wards EDL, NNF and WHO model drug list whereas
prescribers at primary health care level has better access
and information about them. Our findings are supported
by a similar study in a tertiary care hospital in Nepal
where only 0.8% and 2.1% of FDCs were in accordance
with the Nepal and WHO recommended lists of FDCs
respectively [28]. However, a report by Shewade et al.
had documented that almost 61.3% of the FDCs pre-
scribed in Pondicherry, India, were in accordance with
those listed in the WHO recommended list of FDCs
[32]. Although a low usage of FDCs from EDLs does not
always suggest the inappropriate use, the low prevalence
of prescribed FDCs from the established guidelines and
formularies in this study (despite being available free or
at low cost by governments), indicate that their use was
poor. This lead to the irrational use of other FDCs that
has no any established therapeutic justification.
Study limitations
The present study had few limitations. The study was car-
ried out only for a quarter of a year, from February 3rd to
May 3rd 2009, and hence seasonal variation in disease
prevalence and prescribing patterns might have not been
noticed. Background of prescribers at primary, secondary
and tertiary health care centers was not studied, as their
educational background could be potential confounders in
their prescribing practices. In addition, only 100 prescrip-
tions from each setting (primary 100, secondary 100 and
tertiary 100) were included for analysis, which may not rep-
resent the total population attending each health care cen-
ters. Also, this study was conducted few years back in 2009;
the current trends on medication use, their prevalence and
availability might differ now as several interventions might
have been initiated to minimize the use of FDCs.
Recommendations
Educational interventions to improve prescribing prac-
tices at different levels may be required. There is a need
to strengthen the mechanism for continuing professional
development of practitioners to ensure that they possess
the necessary skills and knowledge to prescribe ration-
ally. Government agencies and non- government health
organizations should take a lead in this initiative. The
medical and pharmacy schools must take the responsi-
bility to train their students and young practitioners the
way to access new combinations more logically and
should be based on evidence. There is also need for ad-
equate awareness program for the consumers to be
aware of the hazards of irrational FDCs with careful
monitoring and censoring the misleading claims by
pharmaceutical industries. Further studies over a long
period of time are required to provide a baseline data of
utilization of FDCs which will be beneficial for future
longitudinal studies. Extensive studies on comparison
between the private and government healthcare centers
are urgently required.
Conclusions
Study revealed FDCs are being extensively utilized
among all three levels of health care centers both in pri-
vate and public sectors. Adherence to established guide-
lines and EDLs was much lower in private centers than
in the public ones and so was the case of cost of FDC
prescribing which showed a higher cost among private
sectors. The use of essential medicines was low, and the
FDCs prescribing were not warranted in most occasions.
A needless use of excessive vitamins, minerals and diet-
ary supplements, antimicrobials and analgesic/antipyr-
etic FDCs was noticed in private sectors. Education and
awareness to improve prescription practices at different
healthcare levels may be deemed necessary.
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